Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14208120 | 0.85 | CNR1 (0.39) | NPC1RAB9ALMNACYP1A2NPBWR1 | |
| SCHEMBL241363 | 0.85 | TP53 (0.37) | KIF11ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL27708683 | 0.83 | TP53 (0.36) | KIF11ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL6364875 | 0.83 | TP53 (0.36) | KIF11ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL3958686 | 0.82 | TUBB4A (0.45) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL13699310 | 0.81 | NISCH (0.32) | — | |
| SCHEMBL18986083 | 0.81 | S1PR1 (0.47) | ALDH1A1LMNATP53CYP1A2KDM4E | |
| SCHEMBL24214987 | 0.81 | RAD52 (0.30) | RAD52 | |
| SCHEMBL10640127 | 0.81 | CBFB (0.41) | ALDH1A1ALOX15 | |
| SCHEMBL12686295 | 0.81 | GAA (0.42) | GAACYP2A6NPBWR1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12466973-B2 | Packaging coating containing water-dispersible acrylic block copolymer | SWIMC LLC (US) | 2025-11-11 | — | — | US | disclosed |
| US-12351737-B2 | Chemical mechanical polishing of substrates containing copper and ruthenium | BASF SE (DE) | 2025-07-08 | — | — | US | disclosed |
| EP-4491678-A2 | LATEX COATING COMPOSITION HAVING REDUCED FLAVOR SCALPING PROPERTIES | SWIMC LLC (US) | 2025-01-15 | — | — | EP | disclosed |
| EP-4086314-B1 | LATEX COATING COMPOSITION HAVING REDUCED FLAVOR SCALPING PROPERTIES | SWIMC LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| US-20240002698-A1 | CHEMICAL MECHANICAL POLISHING OF SUBSTRATES CONTAINING COPPER AND RUTHENIUM | BASF SE (DE) | 2024-01-04 | — | — | US | disclosed |
| US-20230416570-A1 | CHEMICAL MECHANICAL POLISHING OF SUBSTRATES CONTAINING COPPER AND RUTHENIUM | BASF SE (DE) | 2023-12-28 | — | — | US | disclosed |
| US-11725117-B2 | Chemical mechanical polishing of substrates containing copper and ruthenium | BASF SE (DE) | 2023-08-15 | — | — | US | disclosed |
| WO-2023064585-A1 | 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | VANDERBILT UNIVERSITY (US) | 2023-04-20 | — | — | WO | disclosed |
| EP-4086314-A1 | LATEX COATING COMPOSITION HAVING REDUCED FLAVOR SCALPING PROPERTIES | SWIMC LLC (US) | 2022-11-09 | — | — | EP | disclosed |
| EP-3484964-B1 | LATEX COATING COMPOSITION HAVING REDUCED FLAVOR SCALPING PROPERTIES | SWIMC LLC (US) | 2022-04-13 | — | — | EP | disclosed |
| US-20070232554-A1 | 3,6-Bridged 9,12-oxolides | ENATA PHARMACEUTICALS, INC. | 2007-10-04 | — | — | US | disclosed |
| US-7229972-B2 | Semisynthetic trimethylenedioxy-erythromycin derivatives and their use in treating bacterial infections and cystic fibrosis; preparation | ENANTA PHARMACEUTICALS, INC. (US) | 2007-06-12 | — | — | US | disclosed |
| US-4215175-A | Non-woven fibers coated with a polymer of ethylenically unsaturated blocked aromatic diisocyanates | THE B. F. GOODRICH COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
| US-4191833-A | BLOCKED WITH PYRAZOLE, ADDITION POLYMERS | THE B.F. GOODRICH COMPANY (US) | 1980-03-04 | — | — | US | disclosed |
| US-4191834-A | BLOCKED WITH BENZIMIDAZOLE, ADDITION POLYMERS | THE B.F. GOODRICH COMPANY (US) | 1980-03-04 | — | — | US | disclosed |
| US-4190582-A | Ethylenically unsaturated blocked aromatic diisocyanates | THE B. F. GOODRICH COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
| US-4189601-A | ADHESIVES, BINDERS FOR NONWOVEN FABRICS | THE B. F. GOODRICH COMPANY (US) | 1980-02-19 | — | — | US | disclosed |
| US-4113958-A | POLYMERS USEFUL AS ADHESIVES AND BINDERS | THE B. F. GOODRICH COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-4101491-A | USEFUL AS BINDERS FOR NONWOVEN FIBERS | THE B. F. GOODRICH COMPANY (US) | 1978-07-18 | — | — | US | disclosed |
| US-4008247-A | POLYMER INTERMEDIATE | THE B. F. GOODRICH COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232554-A1 | 3,6-Bridged 9,12-oxolides | CYP2C9, CYP2C19, CYP2D6 | KIF11 2606/4885ALDH1A1 353/4885SMN1; SMN2 2894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.